Brian Cheng

Stock Analyst at JP Morgan

(1.52)
# 3,097
Out of 5,044 analysts
68
Total ratings
46.3%
Success rate
-10.01%
Average return

Stocks Rated by Brian Cheng

Zymeworks
Oct 16, 2025
Maintains: Overweight
Price Target: $20$23
Current: $19.30
Upside: +19.17%
Allogene Therapeutics
Oct 10, 2025
Downgrades: Underweight
Price Target: n/a
Current: $1.26
Upside: -
Pliant Therapeutics
Oct 10, 2025
Downgrades: Underweight
Price Target: n/a
Current: $1.78
Upside: -
Absci
Oct 2, 2025
Initiates: Overweight
Price Target: n/a
Current: $4.40
Upside: -
Immunovant
Sep 30, 2025
Maintains: Overweight
Price Target: $37$33
Current: $21.98
Upside: +50.14%
CG Oncology
Sep 26, 2025
Maintains: Overweight
Price Target: $41$47
Current: $43.71
Upside: +7.53%
Roivant Sciences
Sep 18, 2025
Maintains: Overweight
Price Target: $16$20
Current: $18.41
Upside: +8.64%
CRISPR Therapeutics AG
Sep 18, 2025
Initiates: Overweight
Price Target: $70
Current: $64.17
Upside: +9.09%
Precigen
Aug 15, 2025
Upgrades: Neutral
Price Target: n/a
Current: $4.06
Upside: -
Immunome
Aug 7, 2025
Maintains: Overweight
Price Target: $23$22
Current: $16.39
Upside: +34.23%
Initiates: Overweight
Price Target: n/a
Current: $33.87
Upside: -
Maintains: Overweight
Price Target: $53$57
Current: $78.51
Upside: -27.40%
Downgrades: Neutral
Price Target: $45$13
Current: $13.96
Upside: -6.88%
Downgrades: Underweight
Price Target: n/a
Current: $3.17
Upside: -
Maintains: Overweight
Price Target: $27$28
Current: $14.25
Upside: +96.49%
Maintains: Overweight
Price Target: $39$33
Current: $7.61
Upside: +333.64%
Downgrades: Neutral
Price Target: $16$6
Current: $2.63
Upside: +128.14%
Upgrades: Neutral
Price Target: $125
Current: $10.23
Upside: +1,121.90%
Maintains: Overweight
Price Target: $17$14
Current: $0.74
Upside: +1,802.95%
Upgrades: Neutral
Price Target: n/a
Current: $4.43
Upside: -
Downgrades: Neutral
Price Target: $20$6
Current: $0.86
Upside: +601.26%
Initiates: Neutral
Price Target: n/a
Current: $2.23
Upside: -
Downgrades: Underweight
Price Target: n/a
Current: $2.38
Upside: -
Maintains: Overweight
Price Target: $71$85
Current: $9.88
Upside: +760.32%
Initiates: Overweight
Price Target: $21
Current: $7.24
Upside: +190.06%